Daxor Corporation

Daxor Corporation has initiated a new outpatient Blood Volume Analysis program at a healthcare facility in eastern Kansas, expanding its Midwestern footprint. The program uses the company’s turnkey ezBVA Lab send-out model, which delivers 98% accurate quantitative blood volume measurements within 24 hours without requiring capital equipment or dedicated lab infrastructure. By directly measuring total blood, plasma, and red cell volume, the service enables clinicians to replace subjective fluid estimation with precise, data-backed decongestion strategies. Daxor’s President and CEO Michael Feldschuh stated that the model eliminates capital and logistical hurdles, allowing high-volume cardiology centers to integrate individualized care that improves outcomes and lowers system costs.